OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/04/2026
Voltar para busca
Dado oficial do USPTO
XINEUR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
17/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
04/12/2023
Data de registro
11/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/02/2025
Última transação
17/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IT
Examinador
MASULLO, MARCO
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
KOLINPHARMA S.P.A.
Representantes
Stephanie N. Nikitenko IpHorgan Ltd
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Industrial chemicals; chemical raw materials for the formulation of pharmaceuticals for humans and animals; chemical raw materials for the formulation of dietetic fooddietetic food not adapted for medical purposesdietetic food adapted for babiespreparations for dietetic food adapted for medical purposesdietetic substances adapted for medical purposesdietetic substances adapted for babiesfood for babies; chemical raw materials for the formulation of dietetic supplements and dietetic preparationsdietary supplements for dietetic purposesfor medical and non-medical purposesdietetic supplements for medical and non-medical purposesdietetic dietary supplementsmedicated dietetic preparations and preparations for use as food additives for humans; cultures of microorganisms other than for medical purposesmicroorganisms for use in food and pharmaceutical manufacture; cultures of saprophytic bacteria other than for medical use; preparations of microorganisms other than for medical usemicroorganisms for use in food and pharmaceutical manufacture; preparations of cultures of saprophytic bacteria other than for medical purposes; bacterial substances for industrial usefor medical purposes; bacteria for use in food manufacture; probiotic bacteria for the food industry for use in food manufacture; bacterial preparations for the food industry; bacterial cultures for the food industry for use in food and pharmaceutical manufacture; milk ferments and bacterial preparations used in making foodstuffs; antioxidantsfatty acidsproteinsenzymesliposomescultures of microorganismsbacteria used in making lactic acid and probiotic compositionsall used in making pharmaceuticalsdietetic compounds for humansfood for babiesfood supplementsnutritional supplementsdietetic supplementsfood supplements for medical purposes and dietetic food; preparations of probiotic bacteria not for medical purposes; enzymes and additiveschemical enzymes and additives for use in fermentation; fermentation extracts for industrial purposesfermentation extracts for use in food manufacture; cultures of microorganismother than for medical and veterinary use
Classe 5
Pharmaceuticalspreparationssubstances and pharmaceutical productsparapharmaceuticalsanitary and hygienic preparationsnamely orthopaedicosteoarticulargynaecologicalurologicalneuropathicophthalmicnutraceuticalnutritionalprobioticprebiotichomeopathicgastroenterologicalimmunologicalotorhinolaryngologicalcardiovasculardermatological and oral hygiene productspharmaceutical preparations for the treatment of musculo-skeletal disorders and for the treatment of infectious diseasespaininflammation and cognitive disorders; nutritionalmineraldieteticnutraceuticalvitaminantioxidants supplements; homeopathic supplements and dietetic food preparations for medical purposesvitamins adapted for pharmaceutical use; enzyme and protein dietary supplementsvegetarian additives; dietary supplements for individuals with special dietary requirementsvitamins; herbal dietary supplements for persons with special dietary requirementsvegetarian supplements; dietary supplement drinks containing magnesiumiron; nutritional supplements for medical purposesdietetic food supplements; dietary supplements for human consumption; food and dietetic food namely food and dietetic food for babies in the nature of pills and bars; cultures of microorganisms for medical purposes; cultures of saprophytic bacteria for medical purposes; preparations of microorganisms for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/03/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/03/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/09/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/08/2025
FIMP
FINAL DISPOSITION PROCESSED
29/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/05/2025
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/12/2024
PUBO
PUBLISHED FOR OPPOSITION
24/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2024
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/11/2024
RFNT
REFUSAL PROCESSED BY IB
30/09/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/09/2024
RFRR
REFUSAL PROCESSED BY MPU
06/09/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/09/2024
CNRT
NON-FINAL ACTION WRITTEN
04/09/2024
DOCK
ASSIGNED TO EXAMINER
23/08/2024
MAFR
APPLICATION FILING RECEIPT MAILED
22/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace XINEUR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.